1.74
0.01 (0.58%)
0.01 (0.58%)
Upgrade to Real-Time
Market Open
Low
1.63
High
10.01
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.01 | 0.58% | 1.74 | 10:20:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.72 | 1.70 | 1.75 | 1.73 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.73 | 1.74 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 429 | 321,735 | $ 1.729 | $ 556,273 | - | 1.63 - 10.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:20:53 | 785 | $ 1.74 | USD |
CytoDyn (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.08B | 619.10M | 377.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 39.22M | $ - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.80 | 2.00 | 1.68 | 1.78 | 1,996,323 | -0.06 | -3.33% |
| 1 Month | 2.01 | 2.20 | 1.68 | 1.92 | 2,148,382 | -0.27 | -13.43% |
| 3 Months | 2.98 | 4.22 | 1.68 | 2.62 | 3,121,605 | -1.24 | -41.61% |
| 6 Months | 5.53 | 7.70 | 1.68 | 3.79 | 4,064,878 | -3.79 | -68.54% |
| 1 Year | 4.30 | 10.01 | 1.63 | 4.20 | 4,971,852 | -2.56 | -59.53% |
| 3 Years | 0.4499 | 10.01 | 0.0552 | 3.24 | 2,835,802 | 1.29 | 286.75% |
| 5 Years | 1.08 | 10.01 | 0.0552 | 3.11 | 1,797,774 | 0.66 | 61.11% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
